Faraday Pharmaceuticals, Inc.
Clinical trials sponsored by Faraday Pharmaceuticals, Inc., explained in plain language.
-
New drug aims to protect the heart during emergency attack treatment
Disease control CompletedThis study tested an experimental drug called FDY-5301, given as a single IV injection during emergency heart attack treatment. The goal was to see if the drug could safely reduce the amount of permanent damage to the heart muscle. About 120 patients who were having a specific ty…
Phase: PHASE2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Breakthrough injection tested to save lives after severe heart attacks
Disease control CompletedThis large, completed Phase 3 trial tested whether an intravenous drug called FDY-5301 could help patients survive and avoid heart failure after a major, life-threatening heart attack (anterior STEMI). Over 2,300 patients who received emergency artery-opening surgery (PCI) were r…
Phase: PHASE3 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC